-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
Recombinant factor XIII (rFXIII): a novel treatment of congenital factor XIII deficiency
Aida Inbal
Drug Evaluation: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
News: Non-small-cell lung cancer in the elderly: updated expert opinion published
News and Views: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
The risks and benefits of prophylactic aspirin in vascular disease and cancer: what is a doctor to do?
Charles H Hennekens, David J Bjorkman
Commentary: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
New hope for bendamustine in the treatment of non-Hodgkin lymphoma
News and Views: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Can mouse models of cancer reliably improve clinical trial outcome?
Grit S Herter-Sprie & Kwok-Kin Wong
Clinical Trail Prospective: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Trial effect: the road from efficacy to effectiveness
Prema Menezes
Editorial: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Telaprevir in the treatment of hepatitis C infection: evidence from the ADVANCE, ILLUMINATE and REALIZE studies
Joseph Ahn, Steven Flamm
Review: Clinical Trail Outcomes: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
New and emerging therapies for gout
Daria B Crittenden, Han Na Kim, Mark C Fisher, David S Goldfarb, Michael H Pillinger
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical evidence of the role of belimumab in the treatment of systemic lupus erythematosus
Ricard Cervera, Gerard Espinosa
Review Article: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings
Kate Bushby, Edward Connor
Proceedings: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
y-secretase inhibitors for treating Alzheimer\\\'s disease: rationale and clinical data
Francesco Panza, Vincenza Frisardi, Bruno P Imbimbo, Davide Seripa, Vincenzo Solfrizzi, Alberto Pilotto
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
Selective estrogen receptor modulators in the treatment of osteoporosis: a review of the clinical evidence
Tobias Johannes de Villiers
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
New advances in the treatment of endometrial cancer
Dario R Roque, Don S Dizon
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Long-term management of atopic dermatitis: evidence from recent clinical trials
Sakari Reitamo ,Johanna M Mandelin, Anita Remitz
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Results and implications of the Trastuzumab for Gastric Cancer (ToGA) trial
Dok Hyun Yoon1 & Yoon-Koo Kang
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation
-
Ethical, clinical and practical considerations in designing clinical trials in pediatric psychopharmacology
Philippe Auby
Review Article: Clinical Investigation